title: Chiral-based therapeutics.
authors.affiliation: Argonex Inc., Charlottesville, VA 22901, USA. apersidis@argonex.com
authors.forename: A
authors.initials: A
authors.lastname: Persidis
mesh_terms: D001709:Biotechnology / Q000592:standards* / Q000639:trends; D015195:Drug Design; D004345:Drug Industry / Q000592:standards / Q000639:trends; D005060:Europe; D007536:Isomerism; D007564:Japan; D013237:Stereoisomerism; D014481:United States; D014486:United States Food and Drug Administration